Product Portfolio

SteadyMed is positioned as a specialty pharmaceutical company, utilizing the unique PatchPump technology as the development platform. As a prefilled, large-volume system, PatchPump has the potential to fulfill needs both in the space beyond existing prefilled injector products, as well as in the chronic/continuous infusion space.

SteadyMed's development portfolio is founded on compounds that:

  • Utilize the PatchPump technology platform to drive innovation in medical treatment paradigms
  • Leverage existing internal technical/clinical/
    regulatory/manufacturing expertise for risk-reduced development programs
  • Maintain an agnostic view toward therapeutic area, yet allow for efficient commercial execution
PatchPump Platform SMT-301 (At Home Patient Analgesia) SMT-201 (At Home Patient Analgesia) Trevyent (Cardiovascular) Development NDA